Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Race AM"'
Autor:
Race AM; Philipps University Marburg, Institute for Medical Bioinformatics and Biostatistics, Marburg, 35043, Germany., Fuchs A; Max Planck Institute for Molecular Genetics, Epigenomics, Berlin, 14195, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center, Berlin, 10115, Germany., Chung HR; Philipps University Marburg, Institute for Medical Bioinformatics and Biostatistics, Marburg, 35043, Germany. ho.chung@staff.uni-marburg.de.; Max Planck Institute for Molecular Genetics, Epigenomics, Berlin, 14195, Germany. ho.chung@staff.uni-marburg.de.
Publikováno v:
Scientific reports [Sci Rep] 2023 Dec 12; Vol. 13 (1), pp. 22020. Date of Electronic Publication: 2023 Dec 12.
Autor:
Heffernan D; Department of Biosciences, TUM School of Natural Sciences, Technical University of Munich (TUM), Garching, Germany., Pilz M; Department of Chemistry, TUM School of Natural Sciences, Technical University of Munich (TUM), Garching, Germany., Klein M; Department of Biosciences, TUM School of Natural Sciences, Technical University of Munich (TUM), Garching, Germany., Haack M; Department of Chemistry, TUM School of Natural Sciences, Technical University of Munich (TUM), Garching, Germany., Race AM; Institute of Medical Bioinformatics and Biostatistics, University of Marburg, Marburg, Germany., Brück T; Department of Chemistry, TUM School of Natural Sciences, Technical University of Munich (TUM), Garching, Germany., Qoura F; Department of Chemistry, TUM School of Natural Sciences, Technical University of Munich (TUM), Garching, Germany., Strittmatter N; Department of Biosciences, TUM School of Natural Sciences, Technical University of Munich (TUM), Garching, Germany. nicole.strittmatter@tum.de.
Publikováno v:
Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2023 Jul; Vol. 415 (18), pp. 4615-4627. Date of Electronic Publication: 2023 Jun 30.
Autor:
Kokesch-Himmelreich J; Bioanalytical Sciences and Food Analysis, University of Bayreuth, Bayreuth, Germany. Electronic address: Julia.Kokesch-Himmelreich@uni-bayreuth.de., Wittek O; Bioanalytical Sciences and Food Analysis, University of Bayreuth, Bayreuth, Germany. Electronic address: Oliver.Wittek@uni-bayreuth.de., Race AM; Bioanalytical Sciences and Food Analysis, University of Bayreuth, Bayreuth, Germany. Electronic address: alan.race@uni-marburg.de., Rakete S; Bioanalytical Sciences and Food Analysis, University of Bayreuth, Bayreuth, Germany. Electronic address: Sophie.Rakete@med.uni-muenchen.de., Schlicht C; Bavarian Health and Food Safety Authority, Oberschleißheim, Germany. Electronic address: Claus.Schlicht@lgl.bayern.de., Busch U; Bavarian Health and Food Safety Authority, Oberschleißheim, Germany. Electronic address: Ulrich.busch@lgl.bayern.de., Römpp A; Bioanalytical Sciences and Food Analysis, University of Bayreuth, Bayreuth, Germany. Electronic address: Andreas.Roempp@uni-bayreuth.de.
Publikováno v:
Food chemistry [Food Chem] 2022 Aug 15; Vol. 385, pp. 132529. Date of Electronic Publication: 2022 Feb 22.
Autor:
Kokesch-Himmelreich J; Bioanalytical Sciences and Food Analysis, University of Bayreuth, Bayreuth 95447, Germany.; German Center for Infection Research (DZIF), Braunschweig 38124, Germany., Treu A; Bioanalytical Sciences and Food Analysis, University of Bayreuth, Bayreuth 95447, Germany.; German Center for Infection Research (DZIF), Braunschweig 38124, Germany., Race AM; Bioanalytical Sciences and Food Analysis, University of Bayreuth, Bayreuth 95447, Germany., Walter K; Infection Immunology, Leibniz Lung Center, Research Center Borstel, Borstel 23845, Germany.; German Center for Infection Research (DZIF), Braunschweig 38124, Germany., Hölscher C; Infection Immunology, Leibniz Lung Center, Research Center Borstel, Borstel 23845, Germany.; German Center for Infection Research (DZIF), Braunschweig 38124, Germany., Römpp A; Bioanalytical Sciences and Food Analysis, University of Bayreuth, Bayreuth 95447, Germany.; German Center for Infection Research (DZIF), Braunschweig 38124, Germany.
Publikováno v:
Analytical chemistry [Anal Chem] 2022 Apr 12; Vol. 94 (14), pp. 5483-5492. Date of Electronic Publication: 2022 Mar 28.
Autor:
Strittmatter N; Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK.; Department of Chemistry, Technical University of Munich, Garching, Germany., Moss JI; Bioscience, Discovery, Oncology R&D, AstraZeneca, Cambridge, UK., Race AM; Institute of Medical Bioinformatics and Biostatistics, University of Marburg, Germany., Sutton D; Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Canales JR; Translational Pathology & Biomarker Analysis, Translational Medicine, R&D Oncology, AstraZeneca, Gaithersburg, MD, USA., Ling S; Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Wong E; Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Cambridge, UK., Wilson J; DMPK, Oncology R&D, AstraZeneca, Cambridge, UK., Smith A; DMPK, Oncology R&D, AstraZeneca, Cambridge, UK., Howes C; DMPK, Oncology R&D, AstraZeneca, Cambridge, UK., Bunch J; National Centre of Excellence in Mass Spectrometry Imaging (NiCE-MSI), National Physical Laboratory, Teddington, UK., Barry ST; Bioscience, Discovery, Oncology R&D, AstraZeneca, Cambridge, UK., Goodwin RJA; Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK.; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Ashford MB; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield UK.
Publikováno v:
Theranostics [Theranostics] 2022 Feb 14; Vol. 12 (5), pp. 2162-2174. Date of Electronic Publication: 2022 Feb 14 (Print Publication: 2022).
Autor:
Strittmatter N; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Department of Chemistry, Technical University of Munich, 85748 Garching, Germany., Richards FM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, U.K.; Translational Medicine, Oncology R&D, Astra Zeneca, Cambridge CB4 0WG, United Kingdom., Race AM; Institute of Medical Bioinformatics and Biostatistics, Philipps University of Marburg, 35032 Marburg, Germany., Ling S; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Sutton D; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Nilsson A; Department of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, 751 24 Uppsala, Sweden.; Science for Life Laboratory, Spatial Mass Spectrometry, Uppsala University, 751 24 Uppsala, Sweden., Wallez Y; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, U.K.; Bioscience, Oncology R&D, AstraZeneca, Cambridge CB2 0RE, United Kingdom., Barnes J; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Maglennon G; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Gopinathan A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, U.K., Brais R; Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, United Kingdom., Wong E; Biologics Engineering, R&D, AstraZeneca, Cambridge CB12 6GH, United Kingdom., Serra MP; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Atkinson J; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Smith A; DMPK, Oncology R&D, AstraZeneca, Cambridge CB2 0RE, United Kingdom., Wilson J; DMPK, Oncology R&D, AstraZeneca, Cambridge CB2 0RE, United Kingdom., Hamm G; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom., Johnson TI; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, U.K., Dunlop CR; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, U.K., Kaistha BP; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, U.K.; Clinical IO group, Early Oncology, AstraZeneca, Cambridge CB12 6GH, United Kingdom., Bunch J; National Centre of Excellence in Mass Spectrometry Imaging, National Physical Laboratory, Teddington TW11 0LW, United Kingdom.; Rosalind Franklin Institute, Didcot OX11 0QS, United Kingdom., Sansom OJ; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom., Takats Z; Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, United Kingdom.; Rosalind Franklin Institute, Didcot OX11 0QS, United Kingdom., Andrén PE; Department of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, 751 24 Uppsala, Sweden.; Science for Life Laboratory, Spatial Mass Spectrometry, Uppsala University, 751 24 Uppsala, Sweden., Lau A; Bioscience, Oncology R&D, AstraZeneca, Cambridge CB2 0RE, United Kingdom., Barry ST; Bioscience, Oncology R&D, AstraZeneca, Cambridge CB2 0RE, United Kingdom., Goodwin RJA; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom., Jodrell DI; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, U.K.; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, United Kingdom.
Publikováno v:
Analytical chemistry [Anal Chem] 2022 Jan 25; Vol. 94 (3), pp. 1795-1803. Date of Electronic Publication: 2022 Jan 10.
Autor:
Balluff B; Maastricht MultiModal Molecular Imaging Institute (M4i), Maastricht University, Maastricht, the Netherlands., Heeren RMA; Maastricht MultiModal Molecular Imaging Institute (M4i), Maastricht University, Maastricht, the Netherlands., Race AM; Institute of Medical Bioinformatics and Biostatistics, Philipps University of Marburg, Marburg, Germany.
Publikováno v:
Journal of mass spectrometry and advances in the clinical lab [J Mass Spectrom Adv Clin Lab] 2021 Dec 18; Vol. 23, pp. 26-38. Date of Electronic Publication: 2021 Dec 18 (Print Publication: 2022).
Autor:
Strittmatter N; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Kanvatirth P; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, U.K., Inglese P; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, U.K., Race AM; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Nilsson A; Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden.; Science for Life Laboratory, Spatial Mass Spectrometry, Uppsala University, 751 24 Uppsala, Sweden., Dannhorn A; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Kudo H; Division of Digestive Diseases, Section of Pathology, Imperial College London, St. Mary's Hospital, London W2 1NY, U.K., Goldin RD; Division of Digestive Diseases, Section of Pathology, Imperial College London, St. Mary's Hospital, London W2 1NY, U.K.; Department of Cellular Pathology, Charing Cross Hospital, London W6 8RF, U.K., Ling S; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Wong E; Biologics Engineering, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Seeliger F; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Serra MP; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hoffmann S; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, U.K., Maglennon G; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hamm G; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Atkinson J; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Jones S; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Bunch J; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, U.K.; National Centre of Excellence in Mass Spectrometry Imaging (NiCE-MSI), National Physical Laboratory, Teddington TW11 0LW, U.K., Andrén PE; Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden.; Science for Life Laboratory, Spatial Mass Spectrometry, Uppsala University, 751 24 Uppsala, Sweden., Takats Z; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, U.K., Goodwin RJA; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, U.K., Mastroeni P; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, U.K.
Publikováno v:
Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2021 Dec 01; Vol. 32 (12), pp. 2791-2802. Date of Electronic Publication: 2021 Nov 12.
Autor:
Strittmatter N; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge CB2 0AA, U.K., England RM; Advanced Drug Delivery, Pharmaceutical Sciences, R&D BioPharmaceuticals, AstraZeneca, Macclesfield SK10 2NA, U.K., Race AM; Institute of Medical Bioinformatics and Biostatistics, Philipps University of Marburg, Marburg 35037, Germany., Sutton D; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge CB2 0AA, U.K., Moss JI; Bioscience, Discovery, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Maglennon G; Oncology Safety, Clinical Pharmacology and Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge CB2 0AA, U.K., Ling S; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge CB2 0AA, U.K., Wong E; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Rose J; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge CB2 0AA, U.K., Purvis I; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge CB2 0AA, U.K., Macdonald R; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge CB2 0AA, U.K., Barry ST; Bioscience, Discovery, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Ashford MB; Advanced Drug Delivery, Pharmaceutical Sciences, R&D BioPharmaceuticals, AstraZeneca, Macclesfield SK10 2NA, U.K., Goodwin RJA; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D BioPharmaceuticals, AstraZeneca, Cambridge CB2 0AA, U.K.; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, U.K.
Publikováno v:
Analytical chemistry [Anal Chem] 2021 Mar 02; Vol. 93 (8), pp. 3742-3749. Date of Electronic Publication: 2021 Feb 19.
Autor:
Race AM; Imaging and AI, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Sutton D; Imaging and AI, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hamm G; Imaging and AI, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Maglennon G; Oncology Safety, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Morton JP; Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, U.K., Strittmatter N; Imaging and AI, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Campbell A; Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K., Sansom OJ; Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, U.K., Wang Y; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Barry ST; Bioscience, Early Oncology, AstraZeneca, Cambridge CB4 0WG, U.K., Takáts Z; Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, U.K., Goodwin RJA; Imaging and AI, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, U.K., Bunch J; Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, U.K.; National Centre of Excellence in Mass Spectrometry Imaging (NiCE-MSI), National Physical Laboratory, Teddington TW11 0LW, U.K.
Publikováno v:
Analytical chemistry [Anal Chem] 2021 Feb 16; Vol. 93 (6), pp. 3061-3071. Date of Electronic Publication: 2021 Feb 03.